Clinical Trial

Hedonic and Homeostatic Appetite Control in Obesity and Type 2 Diabetes in the Context of Meal and Exercise Timing

Study acronym: TIMEX
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The overall aim is to investigate effects of acute exercise on ad libitum energy intake and study whether this differs between morning and evening in individuals with overweight/obesity with or without type 2 diabetes (T2D). Furthermore, the aim is to examine the role of hedonic and homeostatic drivers of appetite control in obesity and T2D in the context of meal and exercise timing.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-03-02; most recent amendment 2025-05-23.
Status change: Recruiting → Active, Not Recruiting 2025-05-23
Trial Details
NCT Number NCT05768958
Lead Sponsor Steno Diabetes Center Copenhagen
Collaborators: University of Leeds, Novo Nordisk A/S
Conditions Overweight and Obesity, Type 2 Diabetes
Enrollment 58 participants
Start Date 2023-03-22
Primary Completion 2024-08-21 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-30